Trial Profile
Effect of treatment with agonist dopaminergics on endometriosic lesions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2009
Price :
$35
*
At a glance
- Drugs Quinagolide (Primary)
- Indications Endometriosis; Hyperprolactinaemia
- Focus Therapeutic Use
- 09 Jan 2009 Status changed from recruiting to completed.
- 19 Mar 2008 New trial record.